AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Chapters Group AG

M&A Activity Mar 14, 2022

5420_rns_2022-03-14_b263d9d7-23b9-4f46-9d8b-e8eb3e6ab3d0.html

M&A Activity

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 14 March 2022 19:03

MEDIQON Group AG: NGC Nachfolgekapital GmbH, a subsidiary of MEDIQON Group AG, entered into a transaction agreement in relation to its subsidiary vetera GmbH

MEDIQON Group AG / Key word(s): Miscellaneous

MEDIQON Group AG: NGC Nachfolgekapital GmbH, a subsidiary of MEDIQON Group AG, entered into a transaction agreement in relation to its subsidiary vetera GmbH

14-March-2022 / 19:03 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


NGC Nachfolgekapital GmbH, a subsidiary of MEDIQON Group AG, entered into a transaction agreement in relation to its subsidiary vetera GmbH

Today, Nordhealth A/S and NGC Nachfolgekapital GmbH, an 80% subsidiary of MEDIQON Group AG agreed that vetera GmbH, an 80% subsidiary of NGC Nachfolgekapital GmbH will become part of the Portfolio of Practice Management Software Companies of Nordhealth A/S.

The consideration will be structured as a mix of cash and shares in Nordhealth A/S.

Vetera is a software and service provider for veterinarians in the DACH region and was acquired by NGC Nachfolgekapital GmbH in June 2019.

With the transaction, NGC Nachfolgekapital GmbH realizes a significant uplift in value compared to the original purchase price paid in 2019. The effect on the Base Value per end of 2021 as calculated by MEDIQON Group AG amounts to c. EUR 0,27 per share. Under German GAAP (“HGB”), there will be no direct impact on the financial statements of MEDIQON Group AG as the parent company. At closing, the shareholder loans granted by MEDIQON Group AG for the acquisition will be fully repaid.

The transaction is expected to close in Q2 2022, subject to satisfaction of customary closing conditions.


14-March-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: MEDIQON Group AG
Herzog-Adolph-Strasse 2
61462 Königstein im Taunus
Germany
Phone: +49 (0) 6174-9687040
Fax: +49 (0) 6174-9687043
E-mail: [email protected]
Internet: www.mediqon-group.de
ISIN: DE0006618309, DE000A254TL0
WKN: 661830, A254TL
Listed: Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart
EQS News ID: 1302161
End of Announcement DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.